Comprehensive pan-cancer analysis reveals CD70 as a promising therapeutic target and biomarker in clear cell renal cell carcinoma
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 142079 - 142079
Published: March 1, 2025
Language: Английский
CD70-targeted cancer theranostics: Progress and challenges
Weijun Wei,
No information about this author
Viktor Grünwald,
No information about this author
Ken Herrmann
No information about this author
et al.
Med,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100671 - 100671
Published: April 1, 2025
Language: Английский
The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma
Cell Death Discovery,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: April 19, 2025
Abstract
Renal
cell
carcinoma
(RCC),
a
therapeutically
recalcitrant
genitourinary
malignancy,
exemplifies
the
profound
interplay
between
oncogenic
signaling
and
metabolic
adaptation.
Emerging
evidence
positions
reprogramming
as
central
axis
of
RCC
pathogenesis,
characterized
by
dynamic
shifts
in
nutrient
utilization
that
transcend
canonical
Warburg
physiology
to
encompass
lipid
anabolism,
glutamine
auxotrophy,
microenvironment-driven
plasticity.
This
orchestrated
rewiring
cellular
energetics
sustains
tumor
proliferation
under
hypoxia
while
fostering
immunosuppression
through
metabolite-mediated
T
exhaustion
myeloid-derived
suppressor
activation.
Crucially,
exhibits
heterogeneity
across
histological
subtypes
intratumoral
regions—a
feature
increasingly
recognized
determinant
therapeutic
resistance.
Our
review
systematically
deciphers
molecular
architecture
metabolism,
elucidating
how
VHL/HIF
mutations,
mTOR
pathway
dysregulation,
epigenetic
modifiers
converge
reshape
glucose
flux,
droplet
biogenesis,
amino
acid
catabolism.
We
present
novel
insights
into
spatial
zonation
within
tumors,
where
pseudohypoxic
niches
engage
lactate
shuttling
cholesterol
efflux
adjacent
vasculature,
creating
pro-angiogenic
immunosuppressive
microdomains.
Therapeutically,
we
evaluate
first-in-class
inhibitors
targeting
rate-limiting
enzymes
de
novo
lipogenesis
proposing
biomarker-driven
strategies
overcome
compensatory
highlight
synergy
glutaminase
PD-1
blockade
reinvigorating
CD8
+
function,
role
lipid-loaded
cancer-associated
fibroblasts
shielding
tumors
from
ferroptosis.
Finally,
outline
translational
roadmap
integrating
multi-omics
profiling,
functional
metabolomics,
biology
match
vulnerabilities
with
precision
therapies.
Language: Английский
Diffusion model assisted designing self-assembling collagen mimetic peptides as biocompatible materials
Xinglong Wang,
No information about this author
Kangjie Xu,
No information about this author
Lingling Ma
No information about this author
et al.
Briefings in Bioinformatics,
Journal Year:
2024,
Volume and Issue:
26(1)
Published: Nov. 14, 2024
Collagen
self-assembly
supports
its
mechanical
function,
but
controlling
collagen
mimetic
peptides
(CMPs)
to
self-assemble
into
higher-order
oligomers
with
numerous
functions
remains
challenging
due
the
vast
potential
amino
acid
sequence
space.
Herein,
we
developed
a
diffusion
model
learn
features
from
different
types
of
human
collagens
and
generate
CMPs;
obtaining
66%
synthetic
CMPs
could
triple
helices.
Triple-helical
untwisting
states
were
probed
by
melting
temperature
(Tm);
hence,
predict
Tm,
achieving
state-of-art
Pearson's
correlation
(PC)
0.95
cross-validation
PC
0.8
for
predicting
Tm
values
CMPs.
Our
chemically
synthesized
short
recombinantly
expressed
long
self-assemble,
lowest
requirement
hydrogel
formation
at
concentration
0.08%
(w/v).
Five
promote
osteoblast
differentiation.
results
demonstrated
using
computer-aided
methods
design
functional
self-assembling
Language: Английский